Back to Search Start Over

Supplementary Table S1 from FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Authors :
Richard Pazdur
Ann T. Farrell
Kirsten B. Goldberg
Gene M. Williams
Rosane Charlab
Christopher M. Sheth
Yuan-Li Shen
Albert Deisseroth
Donna Przepiorka
Sarah E. Dorff
Ramadevi Gudi
Vicky Hsu
Lola Luo
Kelly J. Norsworthy
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Preferred Terms included in grouped terms

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....477f921b3577155839505aca83b12450
Full Text :
https://doi.org/10.1158/1078-0432.22469378